研究多重耐藥蛋白4在第二型糖尿病併發阿斯匹靈阻抗之角色(3/3)

Medicine and Dentistry

1. Acetylsalicylic Acid 100%
2. Maturity Onset Diabetes of the Young 100%
3. Multidrug Resistance Protein 4 100%
4. Aldehyde Reductase 68%
5. Diabetes Mellitus 50%
6. Platelet 43%
7. Thrombocyte Activation 31%
8. Cardiovascular Disease 25%
9. Thrombosis 12%
10. Microvessel 12%
11. Coronary Artery Bypass Graft 6%
12. PFA-100 6%
13. Primary Prevention 6%
14. Physical Disease by Body Function 6%
15. Secondary Prevention 6%
16. Complications of Diabetes Mellitus 6%
17. Blood Stasis 6%
18. Population 6%
19. Fluorescein Sodium 6%
20. Clot Retraction 6%
21. Tandem Mass Spectrometry 6%
22. Apoplexy 6%
23. Thrombocyte Aggregation 6%
24. Liquid Chromatography-Mass Spectrometry 6%
25. Transgenic Mouse 6%
26. Therapeutic Agent 6%
27. Cell Membrane 6%
28. Clinical Trial 6%
29. Glucose Metabolism 6%
30. Electron Microscope 6%

Pharmacology, Toxicology and Pharmaceutical Science

1. Acetylsalicylic Acid 100%
2. Multidrug Resistance Protein 4 100%
3. Non Insulin Dependent Diabetes Mellitus 100%
4. Aldehyde Reductase 68%
5. Diabetes Mellitus 50%
6. Mouse Model 25%
7. Cardiovascular Disease 25%
8. Low Density Lipoprotein Receptor Knockout Mouse 12%
9. Thrombosis 12%
10. Transgenic Mouse 6%
11. Physical Disease by Body Function 6%
12. Fluorescein Sodium 6%
13. Diabetic Complication 6%
14. Clinical Trial 6%
15. Blood Stasis 6%
16. Cerebrovascular Accident 6%